Arcutis Grants 58,500 RSUs, 17,000 Stock Options to Six New Employees

• Arcutis Biotherapeutics granted 58,500 restricted stock units and options to purchase 17,000 common shares to six newly hired employees.
• The awards were granted November 2, 2026, under the 2022 Inducement Plan.
• RSUs vest over four years, with 25% vesting on each annual anniversary of the vesting commencement date.
• Options vest 25% on the first anniversary, with the remainder in 36 equal monthly installments over the following three years.
• The options carry a ten-year term and $31.26 exercise price; all awards require continued employment through applicable vesting dates.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcutis Biotherapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611061600PRIMZONEFULLFEED9871932) on November 06, 2026, and is solely responsible for the information contained therein.